Logo image of NTRS

NORTHERN TRUST CORP (NTRS) Stock Fundamental Analysis

USA - NASDAQ:NTRS - US6658591044 - Common Stock

131.6 USD
-0.62 (-0.47%)
Last: 9/19/2025, 2:37:46 PM
Fundamental Rating

3

Overall NTRS gets a fundamental rating of 3 out of 10. We evaluated NTRS against 237 industry peers in the Capital Markets industry. NTRS has a bad profitability rating. Also its financial health evaluation is rather negative. NTRS has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

In the past year NTRS was profitable.
NTRS had a positive operating cash flow in the past year.
Each year in the past 5 years NTRS has been profitable.
Of the past 5 years NTRS 4 years had a positive operating cash flow.
NTRS Yearly Net Income VS EBIT VS OCF VS FCFNTRS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B -1B 2B

1.2 Ratios

NTRS's Return On Assets of 0.98% is on the low side compared to the rest of the industry. NTRS is outperformed by 65.82% of its industry peers.
NTRS's Return On Equity of 13.03% is fine compared to the rest of the industry. NTRS outperforms 70.04% of its industry peers.
The Return On Invested Capital of NTRS (1.01%) is worse than 70.89% of its industry peers.
The Average Return On Invested Capital over the past 3 years for NTRS is significantly below the industry average of 7.61%.
Industry RankSector Rank
ROA 0.98%
ROE 13.03%
ROIC 1.01%
ROA(3y)0.93%
ROA(5y)0.86%
ROE(3y)11.89%
ROE(5y)11.57%
ROIC(3y)1.06%
ROIC(5y)0.96%
NTRS Yearly ROA, ROE, ROICNTRS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15

1.3 Margins

NTRS has a Profit Margin (11.98%) which is in line with its industry peers.
NTRS's Profit Margin has declined in the last couple of years.
NTRS's Operating Margin of 16.30% is on the low side compared to the rest of the industry. NTRS is outperformed by 63.71% of its industry peers.
NTRS's Operating Margin has declined in the last couple of years.
NTRS's Gross Margin of 56.19% is fine compared to the rest of the industry. NTRS outperforms 66.24% of its industry peers.
In the last couple of years the Gross Margin of NTRS has declined.
Industry RankSector Rank
OM 16.3%
PM (TTM) 11.98%
GM 56.19%
OM growth 3Y-16.14%
OM growth 5Y-8.62%
PM growth 3Y-17.54%
PM growth 5Y-9.62%
GM growth 3Y-18.4%
GM growth 5Y-9.82%
NTRS Yearly Profit, Operating, Gross MarginsNTRS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60 80 100

1

2. Health

2.1 Basic Checks

NTRS has less shares outstanding than it did 1 year ago.
The number of shares outstanding for NTRS has been reduced compared to 5 years ago.
Compared to 1 year ago, NTRS has a worse debt to assets ratio.
NTRS Yearly Shares OutstandingNTRS Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M
NTRS Yearly Total Debt VS Total AssetsNTRS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50B 100B 150B

2.2 Solvency

Based on the Altman-Z score of -0.63, we must say that NTRS is in the distress zone and has some risk of bankruptcy.
NTRS has a worse Altman-Z score (-0.63) than 78.90% of its industry peers.
NTRS has a debt to FCF ratio of 87.39. This is a negative value and a sign of low solvency as NTRS would need 87.39 years to pay back of all of its debts.
Looking at the Debt to FCF ratio, with a value of 87.39, NTRS is in line with its industry, outperforming 42.62% of the companies in the same industry.
A Debt/Equity ratio of 11.95 is on the high side and indicates that NTRS has dependencies on debt financing.
Looking at the Debt to Equity ratio, with a value of 11.95, NTRS is doing worse than 90.72% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 11.95
Debt/FCF 87.39
Altman-Z -0.63
ROIC/WACCN/A
WACCN/A
NTRS Yearly LT Debt VS Equity VS FCFNTRS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5B 10B

2.3 Liquidity

NTRS has a Current Ratio of 0.04. This is a bad value and indicates that NTRS is not financially healthy enough and could expect problems in meeting its short term obligations.
NTRS has a worse Current ratio (0.04) than 95.36% of its industry peers.
A Quick Ratio of 0.04 indicates that NTRS may have some problems paying its short term obligations.
NTRS's Quick ratio of 0.04 is on the low side compared to the rest of the industry. NTRS is outperformed by 95.36% of its industry peers.
Industry RankSector Rank
Current Ratio 0.04
Quick Ratio 0.04
NTRS Yearly Current Assets VS Current LiabilitesNTRS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50B 100B 150B

5

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 28.66% over the past year.
The Earnings Per Share has been growing slightly by 2.76% on average over the past years.
The Revenue has been growing slightly by 0.57% in the past year.
The Revenue has been growing by 18.02% on average over the past years. This is quite good.
EPS 1Y (TTM)28.66%
EPS 3Y2.26%
EPS 5Y2.76%
EPS Q2Q%19.66%
Revenue 1Y (TTM)0.57%
Revenue growth 3Y33.14%
Revenue growth 5Y18.02%
Sales Q2Q%7.8%

3.2 Future

NTRS is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 7.66% yearly.
The Revenue is expected to grow by 3.48% on average over the next years.
EPS Next Y12.47%
EPS Next 2Y9.98%
EPS Next 3Y9.36%
EPS Next 5Y7.66%
Revenue Next Year4.34%
Revenue Next 2Y3.99%
Revenue Next 3Y4.18%
Revenue Next 5Y3.48%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
NTRS Yearly Revenue VS EstimatesNTRS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 5B 10B 15B
NTRS Yearly EPS VS EstimatesNTRS Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2 4 6 8 10

5

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 15.93, which indicates a correct valuation of NTRS.
Compared to the rest of the industry, the Price/Earnings ratio of NTRS is on the same level as its industry peers.
NTRS is valuated rather cheaply when we compare the Price/Earnings ratio to 27.41, which is the current average of the S&P500 Index.
NTRS is valuated correctly with a Price/Forward Earnings ratio of 14.13.
NTRS's Price/Forward Earnings is on the same level as the industry average.
NTRS's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 22.88.
Industry RankSector Rank
PE 15.93
Fwd PE 14.13
NTRS Price Earnings VS Forward Price EarningsNTRS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of NTRS indicates a rather cheap valuation: NTRS is cheaper than 89.45% of the companies listed in the same industry.
NTRS's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. NTRS is cheaper than 64.98% of the companies in the same industry.
Industry RankSector Rank
P/FCF 14.31
EV/EBITDA 9.11
NTRS Per share dataNTRS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 20 40 60

4.3 Compensation for Growth

NTRS's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
PEG (NY)1.28
PEG (5Y)5.77
EPS Next 2Y9.98%
EPS Next 3Y9.36%

6

5. Dividend

5.1 Amount

NTRS has a Yearly Dividend Yield of 2.47%. Purely for dividend investing, there may be better candidates out there.
Compared to an average industry Dividend Yield of 7.96, NTRS has a dividend in line with its industry peers.
NTRS's Dividend Yield is comparable with the S&P500 average which is at 2.38.
Industry RankSector Rank
Dividend Yield 2.47%

5.2 History

The dividend of NTRS has a limited annual growth rate of 3.64%.
NTRS has paid a dividend for at least 10 years, which is a reliable track record.
NTRS has not decreased their dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)3.64%
Div Incr Years0
Div Non Decr Years25
NTRS Yearly Dividends per shareNTRS Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.5 1 1.5 2 2.5

5.3 Sustainability

NTRS pays out 37.49% of its income as dividend. This is a sustainable payout ratio.
The dividend of NTRS is growing, but earnings are growing more, so the dividend growth is sustainable.
DP37.49%
EPS Next 2Y9.98%
EPS Next 3Y9.36%
NTRS Yearly Income VS Free CF VS DividendNTRS Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B -1B
NTRS Dividend Payout.NTRS Dividend Payout, showing the Payout Ratio.NTRS Dividend Payout.PayoutRetained Earnings

NORTHERN TRUST CORP

NASDAQ:NTRS (9/19/2025, 2:37:46 PM)

131.6

-0.62 (-0.47%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryCapital Markets
Earnings (Last)07-23 2025-07-23/bmo
Earnings (Next)10-22 2025-10-22/amc
Inst Owners87.01%
Inst Owner Change-1.44%
Ins Owners0.81%
Ins Owner Change-0.29%
Market Cap25.17B
Analysts55
Price Target126.02 (-4.24%)
Short Float %1.51%
Short Ratio2.24
Dividend
Industry RankSector Rank
Dividend Yield 2.47%
Yearly Dividend3.21
Dividend Growth(5Y)3.64%
DP37.49%
Div Incr Years0
Div Non Decr Years25
Ex-Date09-05 2025-09-05 (0.8)
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)1.33%
Min EPS beat(2)0.77%
Max EPS beat(2)1.89%
EPS beat(4)4
Avg EPS beat(4)5.82%
Min EPS beat(4)0.77%
Max EPS beat(4)10.78%
EPS beat(8)6
Avg EPS beat(8)5.68%
EPS beat(12)6
Avg EPS beat(12)-2.3%
EPS beat(16)9
Avg EPS beat(16)-1.13%
Revenue beat(2)1
Avg Revenue beat(2)-0.37%
Min Revenue beat(2)-2.11%
Max Revenue beat(2)1.37%
Revenue beat(4)1
Avg Revenue beat(4)-0.93%
Min Revenue beat(4)-2.43%
Max Revenue beat(4)1.37%
Revenue beat(8)2
Avg Revenue beat(8)-3.01%
Revenue beat(12)4
Avg Revenue beat(12)-0.59%
Revenue beat(16)5
Avg Revenue beat(16)-0.72%
PT rev (1m)2.1%
PT rev (3m)18.09%
EPS NQ rev (1m)0.66%
EPS NQ rev (3m)9.73%
EPS NY rev (1m)4.73%
EPS NY rev (3m)7.21%
Revenue NQ rev (1m)0.1%
Revenue NQ rev (3m)3.26%
Revenue NY rev (1m)0.52%
Revenue NY rev (3m)2.16%
Valuation
Industry RankSector Rank
PE 15.93
Fwd PE 14.13
P/S 1.8
P/FCF 14.31
P/OCF 9.7
P/B 1.96
P/tB 2.58
EV/EBITDA 9.11
EPS(TTM)8.26
EY6.28%
EPS(NY)9.31
Fwd EY7.08%
FCF(TTM)9.2
FCFY6.99%
OCF(TTM)13.57
OCFY10.31%
SpS73.21
BVpS67.28
TBVpS50.93
PEG (NY)1.28
PEG (5Y)5.77
Profitability
Industry RankSector Rank
ROA 0.98%
ROE 13.03%
ROCE 9.1%
ROIC 1.01%
ROICexc 1.04%
ROICexgc 1.11%
OM 16.3%
PM (TTM) 11.98%
GM 56.19%
FCFM 12.57%
ROA(3y)0.93%
ROA(5y)0.86%
ROE(3y)11.89%
ROE(5y)11.57%
ROIC(3y)1.06%
ROIC(5y)0.96%
ROICexc(3y)1.09%
ROICexc(5y)0.98%
ROICexgc(3y)1.2%
ROICexgc(5y)1.07%
ROCE(3y)10.14%
ROCE(5y)9.75%
ROICexcg growth 3Y19.04%
ROICexcg growth 5Y4.26%
ROICexc growth 3Y17.62%
ROICexc growth 5Y3.85%
OM growth 3Y-16.14%
OM growth 5Y-8.62%
PM growth 3Y-17.54%
PM growth 5Y-9.62%
GM growth 3Y-18.4%
GM growth 5Y-9.82%
F-Score7
Asset Turnover0.08
Health
Industry RankSector Rank
Debt/Equity 11.95
Debt/FCF 87.39
Debt/EBITDA 50.67
Cap/Depr 111.16%
Cap/Sales 5.97%
Interest Coverage 0.33
Cash Conversion 85.55%
Profit Quality 104.9%
Current Ratio 0.04
Quick Ratio 0.04
Altman-Z -0.63
F-Score7
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)113.73%
Cap/Depr(5y)110.62%
Cap/Sales(3y)6.87%
Cap/Sales(5y)7.55%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)28.66%
EPS 3Y2.26%
EPS 5Y2.76%
EPS Q2Q%19.66%
EPS Next Y12.47%
EPS Next 2Y9.98%
EPS Next 3Y9.36%
EPS Next 5Y7.66%
Revenue 1Y (TTM)0.57%
Revenue growth 3Y33.14%
Revenue growth 5Y18.02%
Sales Q2Q%7.8%
Revenue Next Year4.34%
Revenue Next 2Y3.99%
Revenue Next 3Y4.18%
Revenue Next 5Y3.48%
EBIT growth 1Y-1.07%
EBIT growth 3Y11.65%
EBIT growth 5Y7.85%
EBIT Next Year-6.97%
EBIT Next 3Y0.82%
EBIT Next 5YN/A
FCF growth 1Y-23.02%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-13.25%
OCF growth 3YN/A
OCF growth 5YN/A